Skip to content
  • Thursday, 18 June 2026
  • 5:04 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • ETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection
Neuroscience & Brain Research

ETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection

Rifan Muazin Jun 18, 2026 0

A multidisciplinary research team at ETH Zurich has announced the discovery of a novel experimental substance, currently designated as Compound…

Read More
University of Basel Researchers Replicate Human Bone Marrow in Landmark Study to Advance Blood Cancer Research and Reduce Animal TestingCarnegie Scientists Uncover Exotic Superionic State of Carbon Hydride in the Deep Interiors of Ice Giant PlanetsWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine ModificationMapping the Inflammatory Landscape of the Bone Marrow Microenvironment to Predict and Prevent Myeloid Malignancies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
University of Illinois Researchers Identify Glycan-Based Method to Extend Sperm Viability and Enhance IVF Success RatesTakara Bio Unveils Groundbreaking Instrument-Free Spatial Transcriptomics Workflow, Promising Unprecedented Accessibility and ResolutionCanada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patentETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
University of Illinois Researchers Identify Glycan-Based Method to Extend Sperm Viability and Enhance IVF Success Rates
Dwi Wanna Jun 18, 2026
Biotech & Genetic Research
Takara Bio Unveils Groundbreaking Instrument-Free Spatial Transcriptomics Workflow, Promising Unprecedented Accessibility and Resolution
Jia Lissa Jun 18, 2026
Laboratory Automation & Robotics
Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent
Lana Keisha Jun 18, 2026
Neuroscience & Brain Research
ETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection
Rifan Muazin Jun 18, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ